Literature DB >> 1847599

Alpha 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts.

H Xiang1, J H McNeill.   

Abstract

The mechanism(s) involved in diabetes-induced changes in the heart is still unclear, but one defect appears to occur in the alpha 1-adrenoceptor system. We evaluated the possibility that the changes in the inotropic responsiveness to alpha 1-adrenoceptor stimulation in streptozotocin-diabetic rat hearts may be linked to altered phosphoinositide turnover. Stimulation of alpha 1-adrenoceptor by norepinephrine (in the presence of propranolol) in right ventricles resulted in the formation of D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] [measured with an Ins(1,4,5)P3 protein binding assay kit] in a time- and concentration-dependent manner in both control and diabetic rats. The increase in Ins(1,4,5)P3 preceded the increase in the norepinephrine-mediated positive inotropic effect. Diabetic hearts showed a greater maximum inotropic response to norepinephrine stimulation and also had higher Ins(1,4,5)P3 levels. These observations suggest that the changes in Ins(1,4,5)P3 levels may be implicated in the increased inotropic responsiveness to alpha 1-adrenoceptor stimulation in diabetic hearts. Ca2+ overload, induced by Ins(1,4,5)P3, could further be involved in the development of diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847599     DOI: 10.1152/ajpheart.1991.260.2.H557

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Inositol-1,4,5-trisphosphate mass content in isolated perfused rat heart during alpha-1-adrenoceptor stimulation.

Authors:  S Hanem; M Enger; T Skomedal; J B Osnes
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

2.  Upregulation of the alpha1-adrenoceptor-induced phosphoinositide and inotropic response in hypothyroid rat heart.

Authors:  Shahrzad Jalali; Melanie Durston; Vincenzo Panagia; Nasrin Mesaeli
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

Review 3.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 4.  Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

Authors:  Jens Kockskämper; Aleksey V Zima; H Llewelyn Roderick; Burkert Pieske; Lothar A Blatter; Martin D Bootman
Journal:  J Mol Cell Cardiol       Date:  2008-06-15       Impact factor: 5.000

5.  Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy.

Authors:  Paramjit S Tappia; Girma Asemu; Nina Aroutiounova; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

6.  Enhancement of muscarinic receptor-coupled phosphatidyl inositol hydrolysis in diabetic bladder.

Authors:  H Mimata; M A Wheeler; Y Fukumoto; H Takigawa; T Nishimoto; R M Weiss; J Latifpour
Journal:  Mol Cell Biochem       Date:  1995-11-08       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.